Relmada Therapeutics (RLMD) Interest & Investment Income (2014 - 2026)
Relmada Therapeutics (RLMD) reported Interest & Investment Income of $2.3 million for Q2 2026, up 615.9% from $321,458 a year earlier and up 139.8% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Interest & Investment Income (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Relmada Therapeutics' Interest & Investment Income came in at $3.9 million, up 71.4% year-over-year; for FY2025, it was $1.4 million, down 60.5% from FY2024.
- By year, Interest & Investment Income came in at $3.53 million in FY2024 (-31.5%) and $5.15 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Interest & Investment Income in data going back to Q4 2014.
- Year over year, Interest & Investment Income gained in two of the last eight quarters, with growth averaging 51.7%.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2026 (growth of 615.9%); the low point was Q3 2025 (a decline of 71.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $959,762 (Q1 2026), $387,231 (Q4 2025) and $247,013 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | 2.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2026 | 959,762.00 |
| Dec 31, 2025 | 387,231.00 |
| Sep 30, 2025 | 247,013.00 |
| Jun 30, 2025 | 321,458.00 |
| Mar 31, 2025 | 440,287.00 |
| Dec 31, 2024 | 654,642.00 |
| Sep 30, 2024 | 856,478.00 |
| Jun 30, 2024 | 963,013.00 |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 1.11 Mn |
| Sep 30, 2022 | 827,614.00 |
| Jun 30, 2022 | 387,333.00 |
| Mar 31, 2022 | 329,949.00 |
| Dec 31, 2021 | 158,648.00 |
| Sep 30, 2021 | 297,648.00 |
API Access
Relmada Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();